Sunday , November 29 2020

HOW MEDICAL GRADE CBD CAN HELP WITH CHRONIC PAIN & MORE

There are countless ongoing peer-reviewed studies on the medical outcomes of utilizing Cannabis as a drug therapy in patients that have cancer, multiple sclerosis, chronic pain, cognitive damage, rheumatoid arthritis, PTSD, epilepsy, ALS, Crohn’s, Parkinson’s, Lupus, and many other disorders. Medical grade CBD is also a viable alternative for many patients wanting the healing properties of cannabis and its potent antiviral and anti-inflammatory effects but derived from hemp.

The treatment for chronic disorders may require a higher dose mg of CBD for many conditions; in this case, it’s imperative to work with a physician that is experienced with treating a patient’s disorders with medical grade CBD.

Recent studies have shown the following health benefits of CBD:
• Reduces inflammation
• Relaxes organs and tissues
• Relieves pain
• Alleviates Seizures
• Controls & eases muscle spasm
• Anti-nausea
• Anti-psychotic
• Anti-tumor factors
• Brightens skin
• Cancer cell death
• Cancer cell growth inhibitor
• Fights viral infections
• Improves sleep
• Reduces anxiety
• Reduces beta-amyloid plaque
• Reduces cognitive impairment
• Reduces Seizures/anticonvulsant

How Medical Grade CBD works
Our brain and nerve cells have cannabinoid receptors, so our bodies naturally react to cannabis The structure of cannabis interacts directly with our cells. Our natural endocannabinoid system works synergistically with medical marijuana, creating a multitude of beneficial reactions in the body. The endocannabinoid cells have tiny receptors that take in chemicals and produce responses. This natural system in our bodies regulates things like mood, sleeping, immunity, pleasure, memory and much more.

There are two different forms of medical treatment through cannabis. The first is the natural marijuana plant that contains both CBD and THC, and the second is the altered version of the plant that has been through a hybrid process to lighten the THC (tetrahydrocannabinol) level.

CBD or cannabinoids can treat many different forms of diseases and disorders with no THC. THC is the mind-altering, euphoric component of marijuana that gives the “high” feeling. With CBD plants, the THC levels have been extracted through a vigorous process, leaving zero to little THC levels. CBD oil is an excellent alternative for patients that would benefit from cannabinoids alone, while other more complex medical cases require the additional advantages of THC combines with CBD in the marijuana plant.

Cannabis can be quite effective for many conditions that are difficult to treat using traditional pharmaceutical medications. Some of these include fibromyalgia, irritable bowel syndrome, migraine headaches, seizures, PTSD and neuropathic pain. Medical cannabis should certainly be a consideration for those suffering from chronic diseases, or just looking for a more balanced and comfortable life.

BUT BEWARE—NOT ALL CBD IS CREATED
EQUAL—QUALITY AND REGULATION MATTERS.
Verséa is a highly-regarded company in the hemp industry that is founded by professionals with vast healthcare and pharmaceutical experience. The most significant issue for physicians wanting to provide CBD is that Verséa s products are medical grade, and it’s cultivated in the US. Verséa’s products also have high potency and absorption rates due their organic purity and that they are from naturally grown, non GMO plants.

HOW VERSÉA CBD IS DIFFERENT.
Why Verséa? Proprietary High Grade Products
The Verséa product line is clinically driven and scientifically differentiated though formulation processes and technology intended to improve functional attributes and performance of the product.

Pharmaceutical Approach
While Verséa’s commercial Farm Bill CBD is not a pharmaceutical product, Verséa is using pharmaceutical manufacturing and quality standards in the manufacture and control of their commercially available products. These standard include:
• Quality control systems
• Validated manufacturing processes and controls
• Conform to FDA/USDA & cGMP regulatory standards

Proprietary Mechanisms of Action
• Unique & trade-secreted strains
• Defined action in targeted organ systems

Differentiated Formulations
• Patented and trade-secreted technologies
• Utilize Hydrophilic formulation designed to promote bioavailability and absorption
• Unique attributes

Dr. Sunil Panchal is offering medical grade Verséa CBD for his patients. He has seen marked results from patients with chronic pain, fibromyalgia to migraine headaches.

TO FIND OUT MORE AND TO RECEIVE A CODE TO ORDER VERSÉA ONLINE (IF APPROPRIATE), PLEASE SCHEDULE AN APPOINTMENT WITH DR. PANCHAL.

At The National Institute for Pain, their goal is to strive to deliver the highest quality of comprehensive care for those who are suffering from spine, joint, and nerve injuries. They have many alternatives to help you with your personalized treatment needs. Please visit their website at www.nationalinstituteofpain.org, or call them at (813) 264-PAIN (7246).

At the National Institute of Pain, they treat each patient individually, using the latest equipment and various innovative procedures to diagnose pain and determine your care needs. The National Institute of Pain’s President and Founder, Sunil J. Panchal, MD, is a board-certified interventional pain/ minimally invasive spine physician. He earned his Bachelor’s degree in Biology from Rensselaer Polytechnic Institute in Troy, NY, and earned his medical degree from Albany Medical College of Union University in Albany, NY. In addition, Dr. Panchal completed The Business of Medicine Graduate Program at Johns Hopkins University in Baltimore, MD. Dr. Panchal completed an internship in general surgery at the University of South Florida in Tampa, a residency in anesthesiology at Northwestern University in Chicago, IL and a fellowship in interventional pain medicine at the University of Illinois in Chicago. He previously served as co-director of the chronic pain service and director of the multidisciplinary pain fellowship training program at Johns Hopkins University and subsequently as director of the division of pain medicine at Cornell University in New York. He is a member of the North American Spine Society, the North American Neuromodulation Society, the International Neuromodulation Society, and the American Academy of Pain Medicine. Dr. Panchal has authored numerous peer-reviewed journal articles and has served as a reviewer and editor for several journals. He is the co-editor and co-author of the textbook Comprehensive Treatment of Chronic Pain by Medical, Interventional, and Integrative Approaches (2013). Dr. Panchal is a principal investigator in numerous clinical trials, including a current study evaluating sacroiliac joint fusion. Dr. Panchal also served as the Chair of the National Comprehensive Cancer Network Cancer Pain Panel and has lectured widely at the national and international level. He is actively involved in the development of novel analgesics and neurostimulation devices, and in clinical research protocol design.

Verséa CBD
www.nationalinstituteofpain.org

(813) 264-PAIN (7246).

10740 Palm River Rd, Suite 490, Tampa, FL 33619
4911 Van Dyke Rd., Lutz, FL 33558

VIRTUAL VISITS AVAILABLE!

Call to book your next appointment as an office visit or telehealth visit.

Check Also

Lung Cancer

Lung Cancer & COVID-19

According to the American Cancer Society, lung cancer is the leading cause of cancer deaths …